广州白云山医药集团股份有限公司（白云山，股票代码：00874）于2026年5月7日发布截至2026年4月30日止月份的股份变动月报表。本次报告期内，公司已发行股份总数和各类别注册股本均未发生变化，股本结构保持稳定。
根据公告，截至2026年4月末，公司港交所上市的H股股本为219,900,000股，上海证券交易所上市的A股股本为1,405,890,949股，两类股份数量与上月末持平，均无新增发行、购回和注销情况。当月无股份期权或股权激励计划相关变动，也未发生持作库存股的情况。
截至2026年4月30日，白云山的注册股本总额为1,625,790,949元，保持不变。公告显示，公司已严格遵守香港联交所《上市规则》及相关法律法规，并于报告期内未发生影响公司公募股份规模和权属的重大事项。公告由公司秘书黄雪贞签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.